Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | STAT5A |
| Upstream (Parents) |
|---|
| (<<) AKT3 → STAT5A |
| (<<) EML4 → STAT5A |
| (<<) GBP2 → STAT5A |
| (<<) ICAM2 → STAT5A |
| (<<) JAK1 → STAT5A |
| (<<) JAK2 → STAT5A |
| (<<) KLF2 → STAT5A |
| (<<) MAPK1 → STAT5A |
| (<<) MYL6B → STAT5A |
| (<<) NUPR1 → STAT5A |
| (<<) PIP4K2A → STAT5A |
| (<<) PTPN11 → STAT5A |
| (<<) SALL2 → STAT5A |
| Downstream (Children) |
|---|
| STAT5A → CASP8 (>>) |
| STAT5A → CSF2 (>>) |
| STAT5A → EIF4E (>>) |
| STAT5A → FOXO3 (>>) |
| STAT5A → GAD1 (>>) |
| STAT5A → PLA2G3 (>>) |
| STAT5A → RHOT2 (>>) |
| STAT5A → SMOX (>>) |
